Abstract:Objective: This study aimed to assess the impact of preoperative chronic kidney disease (CKD) on the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) who underwent standard radical nephroureterectomy (RNU). Methods: A total of 1172 UTUC patients who received RNU at a single center in Taiwan between February 2005 and August 2019 were included. The patients were categorized into two groups based on their preoperative CKD stage: CKD stage ≤3 (811 patients) and CKD stage >3 (361 patients). The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD) formula. The study investigated the oncological outcomes, including intravesical recurrence, non-urothelial recurrence, and cancer-specific mortality, stratified by preoperative CKD status. Results: The main findings indicated that UTUC patients with CKD stage >3 in Taiwan exhibited a higher proportion of females (p < 0.001), a greater history of concurrent bladder cancer (p = 0.003), more multifocal tumor behavior (p < 0.001), a higher incidence of carcinoma in situ (p = 0.008), increased rates of intravesical recurrence (p < 0.001), a lower prevalence of smoking history (p = 0.003), lower utilization of adjuvant chemotherapy (p < 0.001), reduced occurrence of non-urothelial recurrence (p < 0.001), and lower cancer-specific mortality (p = 0.006) compared to patients with CKD stage ≤3. Multivariate Cox regression analysis revealed significant differences in intravesical recurrence (p = 0.014) and non-urothelial recurrence (p = 0.006) between the CKD stage >3 and CKD stage ≤3 groups. The study also demonstrated that patients with concurrent bladder cancer and variant histology had higher rates of intravesical recurrence, non-urothelial recurrence, and cancer-specific mortality. The CKD stage >3 group exhibited lower rates of intravesical recurrence (p = 0.0014), higher rates of non-urothelial recurrence (p < 0.0001), and increased cancer-specific mortality (p = 0.0091) compared to the CKD stage ≤3 group in the 5-year free survival analysis. Conclusion: In Taiwan, UTUC patients with CKD stage >3 exhibit distinct characteristics compared to the general population with urothelial carcinoma. They are associated with a non-smoking status, a higher proportion of females, and less aggressive pathological features. Additionally, CKD stage >3 can serve as a clinical indicator for intravesical and non-urothelial recurrence. Further investigation into molecular aspects and treatment modifications for these patients is warranted.

Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China

Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation

Risk Factors for Bladder Cancer Recurrence Survival in Patients with Upper-Tract Urothelial Carcinoma

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases

Pattern and Risk Factors of Intravesical Recurrence after Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Large Chinese Center Experience

Comparisons Of Prognosis Between Urothelial Carcinoma Of The Upper Urinary Tract And Bladder With Pt3-4 Cancer

Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China

Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma

[Prognostic Factors of Patients with T2N0M0 Upper Tract Urothelial Carcinoma: a Single-Center Retrospective Study of 235 Patients].

Intravesical Recurrence after Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.

Risk Factors for Upper Tract Urothelial Recurrence Following Local Excision of Bladder Cancer.

Impact of upper tract urothelial carcinoma history on patients with non-muscle-invasive bladder cancer undergoing intravesical chemotherapy

The prognostic factors and analysis of adjuvant chemotherapy for high risk upper tract urothelial carcinoma

Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma

Muscle-invasive upper tract urothelial carcinoma predicts invasive bladder recurrence tumor

Prevalence, Clinicopathological Features, and Prognosis in Upper Tract Urinary Carcinoma Patients with Severe Preoperative Chronic Kidney Disease.

[Clinicopathologic Characteristics and Prognosis of Upper Tract Urothelial Carcinoma: an Analysis of 368 Radical Nephroureterectomy Specimens].

Prevalence and oncologic impact of chronic kidney disease for upper tract urothelial carcinoma in endemic area

Risk Factors and Treatment Outcomes of New Contralateral Upper Urinary Urothelial Carcinoma after Nephroureterectomy: the Experiences of a Large Chinese Center

Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value

[Prognostic Factors for Intravesical Recurrence after Surgery for Upper Tract Urothelial Carcinoma in Renal Transplant Recipients].